August 2021 - Page 23 of 42

FridayAug 13, 2021 12:53 pm

QualityStocksNewsBreaks – LGL Group, Inc. (NYSE American: LGL) Featured in Earnings Release Research at Sidoti

2Q:21 Results Were Helped By Cost Reductions That Aided Strong Margins LGL Group (NYSE American: LGL) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “In our view, LGL shares provide an exciting investment opportunity as we think they could provide outsized upside compared to the risk via its SPAC investment. We believe the proposed potential spin-off of MTronPTI into a separately traded public company would make sense as it would be easier to value it as a standalone company” To access the full report, visit https://ibn.fm/CRKI9 About LGL Group, Inc.…

FridayAug 13, 2021 12:43 pm

QualityStocksNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Highlights Milestones of First Year Under Former ‘Big Tobacco’ Executive Leadership

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) today provided a “year in review” summary of the company’s performance and accomplishments since August 2020 when it added two former “Big Tobacco” players to its executive team. These include Chief Executive Officer Setti Coscarella (former lead strategist for Philip Morris International) and Chief Revenue Officer Tim Corkum (former international commercialization executive for Philip Morris International). Under the leadership of Coscarella and Corkum, the company has completed development of TAAT(TM) and has successfully launched the product at retail in multiple U.S. states with a total store count of more than 500, in addition…

FridayAug 13, 2021 11:45 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Schedules Conference Call to Discuss Q1 2022 Earnings

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), has announced an upcoming teleconference to discuss its financial report for the first quarter ended June 30, 2021. The call is scheduled for Monday, Aug. 16, 2021, at 55 p.m. ET. Richard Wright, WTER president and CEO, and David Guarino, WTER chief financial officer, will host the call. Investors, analysts and other interested parties are invited to participate. U.S. and Canadian callers should dial 877-407-3088; international callers should dial 201-389-0927. All callers will need to use conference ID number 13722270. A…

FridayAug 13, 2021 10:57 am

QualityStocksNewsBreaks – DSG Global Inc.’s (DSGT) Imperium Motors to Showcase Latest EV Technologies at Upcoming Montreal and Quebec Electric Vehicle Shows

DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in rapidly growing market sectors, today announced that Imperium Motors Canada will attend the Montreal Electric Vehicle Show in September and the Quebec Electric Vehicle Show in early October as demand for its electric vehicles (“EVs”) continues to escalate. According to the update, the Montreal Electric Vehicle Show is the largest EV gathering in Canada and runs from September 17-19, 2021, at the Olympic Stadium. The Quebec Electric Vehicle Show, to be held at the Centre de foires de Québec from October 1-3, 2021, attracts…

FridayAug 13, 2021 10:07 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q2 2021 Financial Results, Provides Business Outlook

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today reported its financial results for the quarter ended June 30, 2021. The company also provided a clinical update of its anti-cancer drug candidates currently in development for the treatment of primary and metastatic brain and CNS cancer. “Over the course of the second quarter, our team continued to execute on corporate, clinical and regulatory strategies to drive our Berubicin program toward regulatory approval as fast as possible. We are guided by our…

FridayAug 13, 2021 9:46 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Sees More than $1M in Orders in First Month

Pressure BioSciences (OTCQB: PBIO) announced that PBI Agrochem Inc., its new subsidiary, has received purchase orders totaling more than $1 million in its first month of operation. Agrochem provides ecofriendly agrochemical products, and the orders are for products to be delivered before year end. PBIO, a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, formed the new subsidiary in anticipation of the acquisition of a global agrochemicals products business focused on organically natural and environmentally responsible products. PBI's Ultra…

FridayAug 13, 2021 9:39 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q2 2021 Financial, Operational Report

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has announced its most recent financial report, along with operational highlights for the second quarter, the period ended June 20, 2021. In part, the report noted that second-quarter revenue totaled $4.5 million, an increase of more than 37% year over year, and 30% over the first quarter 2021; revenue for the first half of 2021 totaled $7.9 million. Gross profit for second quarter was $3.6 million with gross margin 81%…

FridayAug 13, 2021 9:36 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Q1 Milestones for Subsidiary — Notes Corrected Information

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has noted key achievements reached by its wholly owned subsidiary Adelia Therapeutics Inc. Most notably, Adelia has achieved key milestones outlined in the terms of a contribution agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and previous Adelia shareholders. Those milestones are for Year 1 Q3 (i)-(iii) and Year 1 Q4 (i) and (iii), as contemplated by the terms of the Dec. 7, 2020, agreement. Consequently, the company announced that, in accordance with the agreement, Class B common shares will be issued to Adelia shareholders…

FridayAug 13, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Shares Insights on the Psychedelics Space on The Dealmaker Podcast

Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the psychedelics industry During the interview, he discussed the potential of psychedelics in the treatment of PTSD and other mental disorders Greg also shared the challenges that the industry is facing currently, mostly to do with legislation McKee also shared how people can help the company and the industry by pushing for the decriminalization of psychedelics and taking part in clinical trials On August 2, 2021, the Dealmaker Podcast posted an interview with Greg McKee, the Chief Executive Officer (“CEO”) of…

Site Search

Company Search

Month: August 2021